BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36239145)

  • 1. Application of pharmacogenomics in supportive oncology: a patient journey.
    Nguyen DG; Morris SA; Patel JN
    Pharmacogenomics; 2022 Oct; 23(15):807-811. PubMed ID: 36239145
    [No Abstract]   [Full Text] [Related]  

  • 2. Deliberations about clinical pharmacogenetic testing in pediatric oncology.
    Issa AM; Aboushawareb SA; Eisenstat DD; Guilcher GM; Liu G; Rassekh SR; Strahlendorf C; Tallen G; Tanoshima R; Carleton B
    Per Med; 2021 Jul; 18(4):399-405. PubMed ID: 33973801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics-guided supportive oncology: A tale of two trials.
    Patel JN; Arnall J; Jandrisevits E; Morse AL; Steuerwald N; Copelan E; Walsh D
    Contemp Clin Trials; 2021 Jun; 105():106391. PubMed ID: 33819640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
    Saulsberry L; Olopade OI
    Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of Supportive Care Pharmacogenomics in Oncology Practice.
    Patel JN; Wiebe LA; Dunnenberger HM; McLeod HL
    Oncologist; 2018 Aug; 23(8):956-964. PubMed ID: 29622698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning of pharmacogenomics resources: moving towards precision oncology.
    Chiu YC; Chen HH; Gorthi A; Mostavi M; Zheng S; Huang Y; Chen Y
    Brief Bioinform; 2020 Dec; 21(6):2066-2083. PubMed ID: 31813953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.
    Andersen RL; Johnson DJ; Patel JN
    Pharmacogenomics; 2016 Mar; 17(4):417-34. PubMed ID: 26871520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical Methods for Establishing Personalized Treatment Rules in Oncology.
    Ma J; Hobbs BP; Stingo FC
    Biomed Res Int; 2015; 2015():670691. PubMed ID: 26446492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
    Kranzler HR; Smith RV; Schnoll R; Moustafa A; Greenstreet-Akman E
    Addiction; 2017 Dec; 112(12):2086-2094. PubMed ID: 28431457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription.
    Maillard M; Louveau B; Vilquin P; Goldwirt L; Thomas F; Mourah S
    Therapie; 2022; 77(2):171-183. PubMed ID: 34922740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: Principles and Relevance to Oncology Nursing
.
    Dodson CH
    Clin J Oncol Nurs; 2017 Dec; 21(6):739-745. PubMed ID: 29149126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern developments in germline pharmacogenomics for oncology prescribing.
    Reizine NM; O'Donnell PH
    CA Cancer J Clin; 2022 Jul; 72(4):315-332. PubMed ID: 35302652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging roles of NGS in clinical oncology and personalized medicine.
    Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
    Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision in cancer pharmacogenomics.
    Kyrochristos ID; Baltagiannis EG; Mitsis M; Roukos DH
    Pharmacogenomics; 2020 Apr; 21(5):311-316. PubMed ID: 32242500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.